Insulet
PODD
#1902
Rank
C$15.55 B
Marketcap
C$224.62
Share price
2.88%
Change (1 day)
-47.56%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

EPS for Insulet (PODD)

EPS in 2026 (TTM): C$5.94

According to Insulet's latest financial reports the company's current EPS (TTM) is C$6.10. In 2025 the company made an earnings per share (EPS) of C$4.97 a decrease over its 2024 EPS that were of C$8.49.

EPS history for Insulet from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$5.9419.59%
2025C$4.97-41.47%
2024C$8.49102.71%
2023C$4.194114.29%
2022C$0.09936-69.57%
2021C$0.33109.09%
2020C$0.16-38.89%
2019C$0.26200%
2018C$0.08516-113.04%
2017C-$0.65-9.8%
2016C-$0.72-60.47%
2015C-$1.8338.71%
2014C-$1.3212.05%
2013C-$1.18-23.15%
2012C-$1.53-12.2%
2011C-$1.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.40 103.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.12-16.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$5.10-16.51%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
C$40.06 556.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
C-$4.36-171.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
C$0.02839-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
C$3.41-44.19%๐Ÿ‡บ๐Ÿ‡ธ USA